Over three decades, Steven has built a long track record of winning high-profile cases and defeating high-stakes litigation, including multimillion-dollar disputes, through tactically executing legal arguments and vigorous advocacy. A skilled litigator and legal strategist, Steven has extensive experience representing businesses and individuals in federal and state courts in California, Texas and across the country, including in class actions, business disputes, mass torts, MDLs, product liability and other complex civil litigation. He is nationally recognized for his expertise in defeating class certification and exposing the legal and scientific flaws in major mass tort litigation, including crafting successful early-dismissal motions and prevailing on summary judgment and related Daubert motions dismantling unreliable expert testimony. Steven represents clients in the consumer products, pharmaceutical, medical device, mass media and entertainment, technology and financial services industries.

Steven’s legal and appellate leadership has been recognized by Best Lawyers in America, and he has repeatedly been named among Lawdragon’s 500 Global Leaders in Crisis Management. He is also ranked nationally in Chambers USA for Product Liability & Mass Torts. Clients told Chambers that Steven is “thoughtful and polished” and “has the ability to make you feel you’re his only client.” Clients also noted that Steven is a “tough-as-nails litigator when he needs to be” and “produces creative arguments for complicated legal issues.” A recognized thought leader, Steven publishes articles and speaks at national conferences on litigation and regulatory challenges facing AI and robotics companies, as well as strategies for defeating innovative theories in class action and mass tort cases. He has repeatedly been selected among the top litigators and thought leaders in Los Angeles and elsewhere.

Representative Matters

  • Lead counsel representing a manufacturer of recalled products in product liability and wrongful death litigation pending in coordinated state court proceedings in California and Delaware.
  • Represented manufacturer of consumer talc product on legal motions practice in trial arising from allegation that product contained trace amounts of asbestos that allegedly contributed to mesothelioma injury.
  • Representing Fortune 500 company in post-trial briefing and appeals from large adverse verdicts in state and federal courts.
  • Represented a leading consumer products manufacturer in putative nationwide and state¬ specific consumer class actions pending in the Central and Northern Districts of California, the District of New Jersey, the Southern District of New York, and the District of Massachusetts arising from the allegedly deceptive labeling and marketing of the company’s pain relief medications, shampoo and conditioner products, and cosmetics.
  • Represented a leading internet company in consumer class action litigation in the Northern District of California, including cases concerning the allegedly defective nature of smartphone devices, and allegedly false and misleading marketing practices; motions to dismiss granted in multiple cases.
  • Represented a major pharmaceutical company, as lead counsel on legal motions and appellate issues, in a federal MDL with more than 10,000 individual cases as well as related coordinated state court proceedings. Drafted and argue Daubert and summary judgment motions granted in lead bellwether cases in the federal and state cases, and prevailed on appeal, and on trial team that secured defense verdict in the only case that ever made it to trial.
  • Represented a major pharmaceutical company in business litigation against other businesses arising from alleged breaches of contract in disputes to be litigated in Delaware or arbitrated in California and New York.
  • Represented corporate defendants in consumer class action litigation pending in the Central District of California related to travel insurance policies during the COVID-19 pandemic.
  • Represented a major music festival company in litigation pending in California state court and the U.S. District Court for the Central District of California seeking the return of millions of dollars owed under performance contracts with musical acts scheduled to perform at a music festival that was prohibited by governmental officials due to the COVID-19 pandemic.
  • Represented a 3D printer technology and products company in trade secret litigation pending in federal court in Florida.
  • Represented a provider of cable television services in consumer class action litigation in the Northern District of California concerning allegedly unfair and deceptive trade practices related to its consumer charging practices and bundling of cable television services, as well as in business tort litigation against a competitor cable and telecommunications company.
  • Represented a leading software company in nationwide consumer class action concerning the allegedly defective nature of the company's software and operating systems that allegedly was uniquely susceptible to hackers and malicious code; motions to dismiss granted and plaintiff chose not to amend complaint.
  • Represented an award-winning writer/director in connection with dispute over joint venture agreement concerning production and distribution of award-winning film.
  • Litigated In re Tobacco II Cases, in all California state court proceedings, in the trial court, intermediate court of appeals, and California Supreme Court, and represented multiple parties concerning the meaning and effect of the standing provisions to California's Unfair Competition Law (Bus. & Prof. Code section 17200) and False Advertising Law (Bus. & Prof. Code section 17500).
  • National counsel for a leading tobacco company for over a decade in class actions, FDA regulatory matters, and domestic and foreign government cost-reimbursement actions; lead legal strategist in, inter alia, defeating class certification in multiple consumer fraud class actions concerning the allegedly deceptive advertising of “light” cigarettes, prevailing in California state coordinated proceedings involving the allegedly deceptive nature of cigarette advertising and marketing practices and the alleged targeting of minors through cigarette advertising, and in a former U.S. territory's multibillion-dollar medical cost-recoupment litigation.
  • Represented an ousted member of a multiplatinum rock ‘n’ roll band in breach of contract and business tort action against the ousting band members, as well as related mediation proceedings; action settled on terms beneficial to client.
  • Represented corporations, producers, and artists in the entertainment industry, including record companies, music publishing companies, motion picture studios, television and film producers, and talent agencies, in complex business disputes, breach of contract actions, copyright and trademark litigation, and class action litigation.
  • Represented a hospitality company in arbitration proceedings against a construction company and general contractor that misappropriated corporate assets and committed fraud; action settled with admission of wrongdoing and repayment of funds.
  • Represented a magazine and its mass media corporate owner defending against a motion picture celebrity’s claims for right of publicity, appropriation of name and likeness, and related Lanham Act claims arising from an article that included a famous photograph of the actor from a film that had been digitally altered in a parody editorial work; prevailed on First Amendment grounds in the Ninth Circuit, after trial on the merits.
  • Represented a magazine and author in defamation and invasion of privacy action filed by former Los Angeles Police Department detective related to a high-profile criminal prosecution of a celebrity arising from a magazine article that first disclosed defense theory that the former detective planted evidence to further incriminate the criminal defendant; action dismissed by plaintiff in face of First Amendment-based motion to dismiss.
  • Represented a leading music publishing company in tort and copyright actions filed by various music performers related to copyrighted works.
  • Represented a manufacturer of consumer goods in regulatory proceedings and a related series of consumer class actions concerning the allegedly false and misleading advertising of its products as natural or unadulterated.

Matters of Note

  • Connolly v. Fisher-Price, Inc., 2025 WL309357 (Cal. App. Jan. 27, 2025) (affirming summary judgment on statute of limitations grounds and rejecting tolling arguments based on New York law).
  • Talford v. Fisher-Price, Inc., 2025 WL 309302 (Cal. App. Jan. 27, 2025) (affirming summary judgment on statute of limitations grounds and rejecting tolling arguments based on North Carolina law).
  • Collaza v. Johnson & Johnson Consumer Inc., 2024 WL 3965933 (S.D.N.Y. Aug. 27, 2024) (dismissing consumer class action on federal preemption grounds), aff’d, 2025 WL 2233746 (2d Cir. Aug. 6, 2025).
  • Musikar-Rosner v. Johnson & Johnson Consumer Inc., 2024 WL 3596897 (D. Mass. July 31, 2024) (dismissing consumer class action on federal preemption grounds)
  • Guinn v. AstraZeneca Pharm. LP, 602 F.3d 1245 (11th Cir. 2010) (affirming defense judgment on Daubert and summary judgment motions).
  • Haller v. AstraZeneca Pharm. LP, 598 F. Supp. 2d 1271(M.D. Fla. 2009) (granting summary judgment and Daubert motions).
  • In re Seroquel Prods. Liab. Litig., No. 6:06-md-01769, 2009 WL 618240 (M.D. Fla. Mar.12, 2009) (same).
  • Scaife v. AstraZeneca LP, No. 06C-04-218, 2009 WL 1610575 (Del. Super. Ct. June 9, 2009) (same).
  • In re Tobacco Cases II (Daniels), 163 P.3d 106 (Cal. 2007) (affirming summary judgment on federal preemption grounds in UCL action based on alleged targeting of cigarette advertising to minors).
  • Mulford v. Altria Grp. Inc., 242 F.R.D. 615 (D.N.M. 2007) (denying class certification in lights litigation).
  • Davies v. Philip Morris U.S.A., Inc., No. 04-2-08174-2, 2006 WL 1600067 (Wash. Super. Ct. May 26, 2006) (denying class certification in lights cigarettes litigation).
  • Californians for Disability Rights v. Mervyn's, LLC, 138 P.3d 207 (Cal. 2006) (lead appellate counsel for amici business associations regarding the application of Proposition 64's amendments to UCL standing requirements to pending cases).
  • Hoffman v. Capital Cities/ABC, Inc., 255 F.3d 1180 (9th Cir. 2001) (directing entry of defense judgment on First Amendment parody grounds), revg, 33 F. Supp. 2d 867 (C.D. Cal.1999).

Presentations and Publications

  • “Federal Preemption In AI And Robotics Is Essential,” Law360 (Feb. 18, 2026)
  • “Crafting Successful Jurisdiction, Standing, and Preemption Arguments at the Motion to Dismiss Stage,” ACI 28th Annual Conference on Drug and Medical Device Litigation, New York, NY (December 6, 2023)
  • “Tactics for Combatting ‘Non-Traditional’ Liability Theories in Drug and Medical Device Product Liability Cases,” ACI 27th Annual Conference on Drug and Medical Device Litigation, New York, NY (December 6, 2022)
  • “How Broad Is the Scope of the CCPA’s Standing Provision Under Section 1798.150(a)(1)?” in California Consumer Privacy Act: A Reference Guide for Compliance (2019)
  • “Making Sense of Private Plaintiff Litigation Under California’s Unfair Competition and False Advertising Statutes After Proposition 64,” The Verdict (2007)
  • “Toxic Torts & Products Liability: Learned-Intermediary Doctrine,” Texas Lawyer (Vol. 23, No. 31 (Oct. 8, 2007).
  • “Advanced Tactics for Defeating Class Certification When Plaintiffs Don’t Need to Prove Individual Knowledge or Reliance,” ACI Defending Fraud Claims in Consumer Class Actions, New York, NY (October 15, 2007)
  • “The Intersection of California’s Unfair Practices Statute and Class Action Litigation,” Law Seminars International “Innovative Strategies for Litigating Class Actions,” Los Angeles, CA (November 12–13, 2007)
     
Read More